Patent · US Expired

Method of detecting the presence of CD155 for diagnosis of cancer and to determine treatment

US6518033B1 · kind B1 · utility

32Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 6, 2000
Grant dateFeb 11, 2003
Priority date
Expiry dateSep 6, 2020

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/70596
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to a method of diagnosing, classifying and grading of tumor growths and to determine whether the use of chimeric polioviruses is a proper course for the treatment of the tumors. More particularly, the method is directed to the use of antibodies to a poliovirus receptor (PVR), CD155, to detect the presence of CD155 on tumor cells in various organs, such as: breast, colon, bronchial passage, epithelial lining of the gastrointestinal, upper respiratory and genito-urinary tracts, liver, prostate and the brain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.